New injection for high blood pressure enters first human safety study
Disease control
Completed
This early-phase trial tested a single dose of SGB-3908, an experimental injectable drug, in 40 healthy volunteers and people with mild high blood pressure. The main goal was to check safety and how the body processes the drug. Researchers also looked at changes in a blood protei…
Phase: PHASE1 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC